Table IV.

Differences between relapsing and non-relapsing patients of active UC group regarding activity of the disease and used treatment

Parameter	Relapsing group (n = 14)	Non-relapsing group (n = 6)	P-value
Clinical activity (Truelove-Witts index)	5 (3–10)	4 (3–9)	0.79
Endoscopic activity (Mayo score)	2 (1–3)	2 (1–2)	0.48
Histopathological activity (Gupta score)	2 (1–3)	2 (1–2)	0.54
Disease location:
Left-sided	15%	16%	0.68
Pancolitis	85%	84%	0.74
Disease duration [weeks]	6 (3–16)	5 (2.5–20)	0.86
Nutritional status:
BMI z-score	–0.3 (–0.7 – 0.3)	–0.5 (–0.7 – 0.1)	0.37
Cole index	85% (80–92%)	83% (78–88%)	0.28
Treatment:
5-ASA	30%	32%	0.82
5-ASA and antibiotics	15%	16%	0.88
5-ASA and antibiotics and steroids	55%	52%	0.76

Data are presented as median values and ranges. BMI – body mass index, 5-ASA – 5 aminosalicylic acid.